Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Idioma
Intervalo de año de publicación
1.
Zh Nevrol Psikhiatr Im S S Korsakova ; 110(5 Pt 2): 44-54, 2010.
Artículo en Ruso | MEDLINE | ID: mdl-21322147

RESUMEN

Two hundreds and eighty patients with heroin addiction were randomized into 4 equal groups. Patients of the group 1 received naltrexone (N) in dosage 50 mg/day and fluoxetine (F) in dosage 20 mg/day during 6 months. Group 2 received N/F-placebo (FN), group 3--N-placebo (NP)/F and group 4--NP/FP. All patients underwent a session of individual psychotherapy for the maintenance of remission. Express urine drugs tests were used for remission control. Compliance was controlled by a riboflavin marker. Clinical state, psychiatric status and social functioning were assessed using quantified international scales and tests. To the end of the 6 month course, 43% of patients of group 1, 36% of group 2, 21% of group 3 and 10% of group 4 were in remission. Therefore, N/F was more effective than F/NP (p < 0.01) and FP/NP (p < 0.001); N/FP was more effective than F/NP (p < 0.05) and NP/FP (p < 0.001); F/NP did not differ significantly from NP/FP (p = 0.1); N/F did not differ from N/FP (p = 0.2). However N/F was more effective compared to N/FP only in women, probably, due to the higher baseline levels of depression, anxiety and anhedonia. Naltrexone was superior to placebo and fluoxetine in the efficacy of maintenance of remission and preventing relapse in patients with heroin addiction. The combination of naltrexone and fluoxetine was more effective compared to the monotherapy with naltrexone in women only.


Asunto(s)
Fluoxetina/uso terapéutico , Dependencia de Heroína/tratamiento farmacológico , Naltrexona/uso terapéutico , Antagonistas de Narcóticos/uso terapéutico , Inhibidores Selectivos de la Recaptación de Serotonina/uso terapéutico , Adolescente , Adulto , Método Doble Ciego , Quimioterapia Combinada , Femenino , Humanos , Masculino , Placebos , Inducción de Remisión , Adulto Joven
2.
Artículo en Ruso | MEDLINE | ID: mdl-15481924

RESUMEN

Changes in fine morphological structures of E. coli, S. aureus and spores of B. anthracis vaccine strain STI under the action of the disinfectant "Veltolen" manufactured by the Closed Joint-Stock Company "Velt", were evaluated. When used at concentrations of 0.0025-0.025%, the preparation induced the loosening of the cell wall in all microorganisms under study, the intensive formation of bubbles on the cell wall surface with their subsequent separation from the cell wall and the formation of "rosettes". In case of more prolonged exposure (up to 60 minutes) and higher concentrations of the preparation these phenomena became more intensive and finally led to the destruction of bacterial cells.


Asunto(s)
Bacillus anthracis/efectos de los fármacos , Desinfectantes/farmacología , Escherichia coli/efectos de los fármacos , Compuestos de Amonio Cuaternario/farmacología , Staphylococcus aureus/efectos de los fármacos , Alcoholes , Bacillus anthracis/fisiología , Pared Celular/efectos de los fármacos , Pared Celular/ultraestructura , Relación Dosis-Respuesta a Droga , Escherichia coli/ultraestructura , Esporas Bacterianas/efectos de los fármacos , Esporas Bacterianas/ultraestructura , Staphylococcus aureus/ultraestructura , Factores de Tiempo , Agua
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA